Alkem Laboratories Ltd.
BSE: 539523 | Sector: Health care |
NSE: ALKEM | ISIN Code: INE540L01014 |
BSE 00:00 | 20 Jan | 3083.45 |
29.95 (0.98%) |
OPEN
3053.50 |
HIGH
3103.80 |
LOW
3039.60 |
NSE 00:00 | 20 Jan | 3083.25 |
30.40 (1.00%) |
OPEN
3076.65 |
HIGH
3103.00 |
LOW
3035.45 |
OPEN | 3053.50 |
PREVIOUS CLOSE | 3053.50 |
VOLUME | 3202 |
52-Week high | 3150.00 |
52-Week low | 1950.00 |
P/E | 23.92 |
Mkt Cap.(Rs cr) | 36,863 |
Buy Price | 3080.00 |
Buy Qty | 103.00 |
Sell Price | 3097.90 |
Sell Qty | 2.00 |
About Alkem Laboratories Ltd.
Headquartered in Mumbai India Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics generic drugs active pharmaceutical ingredients (APIs) and nutraceuticals which it markets in India and international markets. Wi...> More
Alkem Laboratories Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
36,863 | |
EPS - TTM | (![]() |
[*S] | 128.90 |
P/E Ratio | (X) | [*S] | 23.92 |
Face Value | (![]() |
2 | |
Latest Dividend | (%) | 150.00 | |
Latest Dividend Date | 10 Aug 2020 | ||
Dividend Yield | (%) | 0.81 | |
Book Value / Share | (![]() |
[*S] | 599.29 |
P/B Ratio | (![]() |
[*S] | 5.15 |
News
Alkem Laboratories Ltd - Financial Results
Particulars (![]() |
Sep 2020 | Sep 2019 | % Chg |
Net Sales | 2362.8 | 2264.03 | 4.36 |
Other Income | 35.54 | 31.42 | 13.11 |
Total Income | 2398.34 | 2295.45 | 4.48 |
Total Expenses | 1762.31 | 1811.44 | -2.71 |
Operating Profit | 636.03 | 484.01 | 31.41 |
Net Profit | 481.51 | 380.52 | 26.54 |
Equity Capital | 23.91 | 23.91 | - |
Alkem Laboratories Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Lupin | 1087.45 | -0.25 | 49315.86 |
Torrent Pharma. | 2722.60 | -1.01 | 46071.84 |
Gland Pharma | 2274.80 | -0.56 | 37147.48 |
Alkem Lab | 3083.45 | 0.98 | 36862.64 |
Piramal Enterp. | 1596.40 | 0.37 | 36006.80 |
Abbott India | 14404.00 | -1.38 | 30608.50 |
Ipca Labs. | 2104.15 | -0.92 | 26691.14 |
Alkem Laboratories Ltd - SHAREHOLDING PATTERN
|
|
Alkem Laboratories Ltd - Research Reports
Date | Broker | Action | Price | Report |
10/02/2020 | Anand Rathi | Buy | 2505 | ![]() |
13/11/2019 | India Nivesh Securities | Accumulate | 1964 | ![]() |
Alkem Laboratories Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -0.15% | -0.27% | 0.61% | 0.55% |
1 Month | 4.26% | 4.38% | 6.03% | 6.43% |
3 Month | 15.83% | 15.66% | 22.81% | 23.10% |
6 Month | 23.03% | 22.97% | 33.07% | 32.87% |
1 Year | 30.64% | 30.68% | 19.90% | 19.80% |
3 Year | 39.60% | 38.95% | 40.21% | 34.42% |
Alkem Laboratories Ltd - STOCK STRENGTH
Today's Low/High | 3039.60 | 3103.80 | |
Week Low/High | 2989.60 | 3127.00 | |
Month Low/High | 2758.75 | 3150.00 | |
YEAR Low/High | 1950.00 | 3150.00 | |
All TIME Low/High | 1175.00 | 3150.00 |
Quick Links for Alkem Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices